With two major physician acquisitions under its belt and plans to overhaul how it pays for drugs, CVS aims to prioritize the patient experience.
Driving the news: After holding its first investor day in two years, Tuesday CVS announced plans to use a more "transparent" model that could reduce secrecy around drug prices.
